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Background: The rs17145738 single nucleotide polymorphism (SNP) near MLX interacting protein-like/transducin
(beta)-like 2 (MLXIPL/TBL2) loci is associated with serum lipid levels, but the results are inconsistent in diverse
ethnic/racial groups. The current study was to investigate the association of MLXIPL/TBL2 rs17145738 SNP and
several environmental factors with serum lipid profiles in the Guangxi Mulao and Han populations.
Methods: A total of 649 subjects of Mulao nationality and 712 participants of Han nationality aged 16–84 years
were randomly selected from our previous stratified randomized samples. Genotyping was performed by
polymerase chain reaction and restriction fragment length polymorphism combined with gel electrophoresis, and
then confirmed by direct sequencing.
Results: Serum apolipoprotein (Apo) B levels were higher in Mulao than in Han (P < 0.001). There were no
significant differences in the genotypic and allelic frequencies of the MLXIPL/TBL2 rs17145738 SNP between the two
ethnic groups or between males and females. The T allele carriers had higher triglyceride (TG) and ApoB levels in
Mulao, and higher total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels in Han than the T
allele non-carriers (P < 0.05 for all). Subgroup analyses showed that the T allele carriers had higher ApoB levels in
both Mulao and Han females than the T allele non-carriers, but the T allele carriers had lower ApoB levels in Han
males than the T allele non-carriers (P < 0.05, respectively). The T allele carriers in Han had higher TC, high-density
lipoprotein cholesterol (HDL-C) levels and ApoA1/ApoB ratio and lower TG levels in males, and higher LDL-C levels
and lower ApoA1/ApoB ratio in females than the T allele non-carriers (P < 0.05 for all). Serum TC levels in the
combined population of the two ethnic groups and in Han, and HDL-C levels in Han males were correlated with
genotypes (P < 0.05 for all). Serum lipid parameters were also correlated with several environmental factors
(P < 0.05-0.01).
Conclusions: The association of MLXIPL/TBL2 rs17145738 SNP and serum lipid profiles is different between the
Mulao and Han populations. There is a sex-specific association in the both ethnic groups.Introduction
Compelling evidence has demonstrated that serum lipid
and lipoprotein concentrations are tightly associated
with coronary artery disease (CAD) [1] which is the
major leading causes of death and disability worldwide
[2], and targets for therapeutic intervention [1,3]. It is* Correspondence: yinruixing@163.com
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by genetic [4,5] and multiple environmental risk factors
[6,7] and their interactions [8-10]. Twin and family stud-
ies have suggested that approximately half of the inter-
individual variants in serum lipid phenotypes can be ex-
plained by genetic variants [11].
During the past few years, genome-wide association
studies (GWAS) have shown great success in identified
several novel variants associated with plasma lipid and
lipoprotein levels [4,5,12,13], such as single nucleotide
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loci. MLXIPL/TBL2 loci containing genes encoding
TBL2 and MLXIPL which is also called carbohydrate-
responsive element binding protein (chREBP). TBL2 is
associated with triglyceride (TG) metabolism [14]. Re-
search has showed that ectopic TBL2 over-expression
significantly reduces cellular cholesterol and miRNA-
mediated knockdown raises 15-30% cholesterol levels.
However the role for TBL2 in modulation of cellular
cholesterol is undefined at this time. The mechanism of
MLXIPL in lipid metabolism is also unclear in detail, the
function of MLXIPL as a transcriptional mediator is de-
scribed to connect glycolysis with lipogenesis, and regu-
late lipogenesis and glucose utilization in the liver by a
phosphorylation/dephosphorylation pathway. In the liver,
chREBP mediates activation of several regulator enzymes
of glycolysis and lipogenesis [15,16]. When the hepato-
cytes have ample glucose, xylulose-5-phosphate is pro-
duced in the pentose phosphate pathway and activates
protein phosphatase 2A, which dephosphorylates
chREBP and activated it translocated to the nucleus. Nu-
clear chREBP combined with MLX and binds carbohy-
drate response elements to channel the transcription of
genes involved in glycolysis, lipogenesis, TG synthesis
and very-low-density lipoprotein secretion.
The rs17145738 SNP is a C > T variation located on
human chromosome 7 (http://www.ncbi.nlm.nih.gov/gene)
downstream of MLXIPL/TBL2 loci and is confirmed to be
relevant to TG metabolism [4,12,17], but the results are
controversial in prior studies. The inconsistent results
should invigorate interest in characterize the full impact of
the relationship between the rs17145738 SNP and serum
lipid profiles. Furthermore, the replication of this associ-
ation has not been detected in the Chinese minorities so
far.
China is a multiethnic country. Other than the major-
ity Han nationality, there are 55 ethnic minorities living
in China. Most of these minorities inhabit peripheral re-
gions of China, especially border provinces such as
Guangxi, where special landforms like the Karst Moun-
tains vastly influenced their lives and history. Mulao na-
tionality is one of the 55 minorities with population of
207,352 (the fifth national census statistics of China in
2000). Ninety percent of them live in the Luocheng
Mulao Autonomous County of Hechi, Guangxi Zhuang
Autonomous Region, People’s Republic of China. A pre-
vious study has shown that the genetic relationship be-
tween Mulao nationality and other minorities in
Guangxi was much closer than that between Mulao and
Han or Uighur nationality [18]. To the best of our know-
ledge, however, the association of rs17145738 SNP and
serum lipid levels has not been previously reported in
this population. Therefore, the aim of the present study
was to detect the association of MLXIPL/TBL2 rs17145738SNP and several environmental factors with serum lipid
profiles in the Mulao and Han populations.
Materials and methods
Study population
The study included 649 unrelated subjects of Mulao na-
tionality from Luocheng Mulao Autonomous County,
Guangxi Zhuang Autonomous Region, Pepole’s Republic
of China. All of the subjects were randomly selected
from our previous stratified randomized samples [9,10].
The age of the subjects ranged from 16 to 84 years,
mean age was 52.40 ± 15.61 years. There were 290 males
(44.68%) and 359 females (55.32%). We simultaneously
surveyed 712 subjects of Han nationality who reside in
the same villages by the same method. The mean age of
the subjects was 52.55 ± 15.24 years (range 16–84 years).
There were 316 males (44.38%) and 396 females
(55.62%).
All study subjects were healthy peasants, and had no
evidence of diseases related to atherosclerosis, CAD and
diabetes. None of them had been treated with β-
adrenergic blocking agents and lipid-lowering medica-
tions such as statins or fibrates. The present study was
approved by the Ethics Committee of the First Affiliated
Hospital, Guangxi Medical University. All participants
gave written informed consent.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods [19]. Information on demographics,
socioeconomic status and lifestyle was collected with
standardized questionnaires. The alcohol information
included questions about the number of liangs (about
50 g) of rice wine, corn wine, rum, beer, or liquor con-
sumed during the preceding 12 months. Alcohol con-
sumption was categorized into subgroups of grams of
alcohol per day: < 25 and ≥ 25. Smoking status was cate-
gorized into subgroups of cigarettes per day: < 20 and ≥
20. The physical examination included body height, body
weight, and waist circumference. Sitting blood pressure
was measured three times with the use of a mercury
sphygmomanometer after a 5-minute of rest, and the
average of the three measurements was recorded. Sys-
tolic blood pressure was determined by the first Korotk-
off sound, and diastolic blood pressure by the fifth
Korotkoff sound. Hypertension was diagnosed according
to the criteria of 1999 World Heath Organization-
International Society of Hypertension Guidelines for the
management of hypertension [20]. Body weight was
measured using a portable balance scale. Subjects were
weighed in a minimum of clothing with shoes off.
Height was measured using a stadiometer. Body mass
index (BMI) was calculated as weight (kg) divided by
height (m) squared. Normal weight, overweight and
Figure 1 Electrophoresis of PCR products of the samples. Lane
M: 100 bp marker ladder; lanes 1–6: samples. The 415 bp bands are
the target fragments.
Figure 2 Genotyping of the MLXIPL/TBL2 rs17145738 SNP. Lane
M: 100 bp marker ladder; lanes 1 and 2: TT genotype (366 bp); lanes
3 and 4: CC genotype (253- and 113-bp); and lanes 5 and 6: CT
genotype (366-, 253-, and 113-bp). The 49-bp fragments were
invisible in the gel owing to its fast migration speed.
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m2; respectively [21].
Biochemical analyses
The subjects who did not fast or fasted < 12 hours were
excluded before testing. Venous blood sample was
drawn from a forearm vein. A part of the sample was
collected into a glass tube and used to determine serum
lipid levels. Another part of the sample was transferred
into a tube with anti-coagulate solution (4.80 g/L citric
acid, 14.70 g/L glucose, and 13.20 g/L tri-sodium citrate)
and used to extract deoxyribonucleic acid (DNA). The
levels of total cholesterol (TC), TG, high-density lipopro-
tein cholesterol (HDL-C) and low-density lipoprotein
cholesterol (LDL-C) in the samples were measured using
standard enzymatic methods. Serum apolipoprotein
(Apo) A1 and ApoB levels were assessed by the immu-
noturbidimetric immunoassay. The ratio of ApoA1 to
ApoB was calculated. All determinations were performed
with an autoanalyzer (Type 7170A; Hita-chi Ltd, Tokyo,
Japan) in the Clinical Science Experiment Center of the
First Affiliated Hospital, Guangxi Medical University.
The normal ranges of serum TC, TG, HDL-C, LDL-C,
ApoA1, ApoB levels and the ratio of ApoA1 to ApoB in
our Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 1.16-1.42, 2.70-3.10 mmol/L, 1.20-1.60, 0.80-
1.05 g/L, and 1.00-2.50; respectively. The individuals
with TC > 5.17 mmol/L, and/or TG > 1.70 mmol/L were
defined as hyperlipidemic [7].
DNA preparation and genotyping
Genomic DNA was isolated from peripheral blood leuko-
cytes using the phenol-chloroform method [7]. Genotyping
of the rs17145738 SNP was performed by the polymerase
chain reaction and restriction fragment length polymorph-
ism (PCR-RFLP). The PCR amplification was performed
using the following primers: F: 5'-ATGGTCCAG
GAGTCTGCCC-3' and R: 5'-AGCCATCGTGCCTAGC
TAAA-3' (Sangon Biotech Co., Ltd., Shanghai, People’s Re-
public of China). Each amplification reaction was set up in
25 μL obtained by adding: 12.5 μL 2 × Taq PCR MasterMix
(constituent: 0.1 U Taq polymerase/μL, 500 μM dNTP each
and PCR buffer); 1.0 μL of each primer (10 μmol/L); 2 μL
genomic DNA (100 ng) and ultrapure H2O until reaching
the final volume. The PCR condition was as follows: initial
denaturation at 95°C for 5 min, followed by 32 cycles of de-
naturation at 95°C for 45 s, annealing at 63°C for 30 s,
elongation for 45 s at 72°C and a final extension of 7 min at
72°C. Then 2 U of TaaI restriction enzyme, 9.0 μL
nuclease-free water and 1.0 μL of 10 × buffer solution were
added directly to the PCR products (5 μL) and digested at
65°C overnight, and then the fragments were separated by
electrophoresis in a 2% agarose gel for 50 min at 120 V.
The products of 415 bp nucleotide sequences were foundin all samples (Figure 1). The PCR products have two en-
zyme restriction sites, one is inherently and another is the
genotype identification mark. The genotypes indentified
were named according to the presence or absence of the
enzyme restriction sites, when a C to T transition at
rs17145738 locus in the MLXIPL-TBL2 region. The
Figure 3 Partial nucleotide sequences of the MLXIPL/TBL2 rs17145738 SNP. (A) CC genotype, (B) CT genotype, and (C) TT genotype.
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absence indicates the T allele (cannot be cut). Thus, the TT
genotype is homozygote for the absence of the site (band at
366 bp), CT genotype is heterozygote for the presence and
absence of the site (bands at 366-, 253-, and 113-bp), and
CC genotype is homozygote for the presence of the site
(bands at 253- and 113-bp). Because of the inherent en-
zyme sites, all PCR products were cut out a 49-bp frag-
ment. The 49-bp fragment was invisible in the gel owing to
its fast migration speed (Figure 2). Genotypes were scored
by an experienced reader blinded to the epidemiological
data and serum lipid levels. The genotypes were also con-
firmed randomly by DNA sequencing (Figure 3, Sangon
Biotech Co., Ltd., Shanghai, People’s Republic of China).
Statistical analyses
All statistical analyses were performed using SPSS 16.0
(SPSS Inc., Chicago, IL, USA). Quantitative variables were
represented as mean ± standard deviation (serum TG levels
were represented as medians and inter-quartile ranges).
Qualitative variables were expressed as percentages. Com-
parisons of mean values of general characteristics betweenMulao and Han were performed with the Student’s un-
paired t-test. Allelic and genotypic frequencies were deter-
mined via direct counting, and the standard goodness-of-fit
test was used to test the Hardy-Weinberg equilibrium. Dif-
ference in genotype distribution between the groups was
tested by the Chi-square test. The association of genotypes
and serum lipid parameters was tested by analysis of covari-
ance (ANCOVA). Sex, age, BMI, blood pressure, alcohol
consumption, and cigarette smoking were adjusted for the
statistical analysis. In order to evaluate the association of
serum lipid levels and genotypes (CC = 1, CT/TT = 2) or
several environmental factors, multivariable linear regres-
sion analysis with stepwise modeling was also performed
in the combined population of Mulao and Han, Mulao,
Han, males, and females; respectively. A P value (two-
tailed) of less than 0.05 was considered statistically
significant.
Results
General characteristics and serum lipid levels
The general characteristics and serum lipid levels be-
tween the Mulao and Han populations are presented in
Table 1 Comparison of demographic, lifestyle characteristics and serum lipid levers between the Mulao and
Han populations
Parameter Mulao Han t (x2) P
Number 649 712 - -
Male/Female 290/359 316/396 0.013 0.911
Age (years) 52.40 ± 15.61 52.55 ± 15.24 −0.172 0.863
Height (cm) 155.21 ± 8.05 154.23 ± 8.20 2.236 0.025
Weight (kg) 52.81 ± 9.05 53.17 ± 8.90 −0.745 0.456
Body mass index (kg/m2) 21.87 ± 3.02 22.36 ± 3.55 −2.734 0.006
Waist circumference (cm) 75.15 ± 8.49 75.09 ± 7.34 0.135 0.893
Systolic blood pressure (mmHg) 129.63 ± 21.76 130.21 ± 19.23 −0.521 0.603
Diastolic blood pressure (mmHg) 81.05 ± 11.57 82.79 ± 11.20 −2.825 0.005
Pulse pressure (mmHg) 48.59 ± 16.45 47.42 ± 14.87 1.369 0.171
Cigarette smoking [n (%)]
Nonsmoker 482 (74.3) 502 (70.5)
< 20 cigarettes/day 145 (22.3) 185 (26.0) 2.536 0.281
≥ 20 cigarettes/day 22 (3.4) 25 (3.5)
Alcohol consumption [n (%)]
Nondrinker 493 (76.0) 555 (77.9)
< 25 g/day 55 (8.5) 76 (10.6) 6.329 0.042
≥ 25 g/day 101 (15.5) 81 (11.4)
Blood glucose 6.01 ± 1.62 6.10 ± 1.64 −1.034 0.301
Total cholesterol (mmol/L) 5.07 ± 1.35 5.02 ± 1.01 0.688 0.492
Triglyceride (mmol/L) 1.08 (0.80-1.60) 1.06 (0.80-1.64) −0.602 0.547
HDL-C (mmol/L) 1.76 ± 0.47 1.74 ± 0.53 0.735 0.462
LDL-C (mmol/L) 2.93 ± 0.70 2.89 ± 0.82 0.767 0.443
Apolipoprotein (Apo) Al (g/L) 1.33 ± 0.40 1.34 ± 0.25 −0.808 0.419
ApoB (g/L) 0.97 ± 0.54 0.86 ± 0.19 5.051 0.000
ApoA1/ApoB 1.62 ± 1.03 1.64 ± 0.46 −0.381 0.703
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of triglyceride was presented as median (interquartile range), the
difference between the two ethnic groups was determined by the Wilcoxon-Mann–Whitney test.
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were lower but the levels of ApoB, body height and the
percentages of subjects who consumed alcohol were
higher in Mulao than in Han (P < 0.05-0.001). There
were no differences in the levels of age, body weight,
waist circumference, systolic blood pressure, serum TC,
TG, HDL-C, LDL-C, ApoA1, and the ratio of ApoA1 to
ApoB or male to female, the percentages of subjects who
smoked cigarettes between the two ethnic groups
(P > 0.05 for all).
Genotypic and allelic frequencies
Table 2 shows the genotypic and allelic frequencies of
MLXIPL/TBL2 rs17145738 SNP. The genotype distribu-
tion was in Hardy-Weinberg equilibrium. The frequen-
cies of C and T alleles were 92.99% and 7.01% in Mulao,
and 93.40% and 6.60% in Han (P > 0.05); respectively.
The frequencies of CC, CT and TT genotypes were86.10%, 13.70% and 0.20% in Mulao, and 87.50%, 11.80%
and 0.70% in Han (P > 0.05); respectively. The genotypic
and allelic frequencies were also not different between
males and females in the both ethnic groups (P > 0.05).
Genotypes and serum lipid levels
As shown in Table 3, the levels of TG and ApoB were
different between the CC and CT/TT genotypes in
Mulao (P < 0.05 for each) but not in Han, the T allele
carriers had higher TG and ApoB levels than the T allele
non-carriers. The levels of TC and LDL-C in Han but
not in Mulao were different between the CC and CT/TT
genotypes (P < 0.05 for each), the T allele carriers had
higher TC and LDL-C levels than the T allele non-
carriers.
Subgroup analyses according to gender showed that
the levels of ApoB in Mulao females but not in males
were different between the CC and CT/TT genotypes
Table 2 Comparison of the genotypic and allelic
frequencies of the rs17145738 SNP between the Mulao
and Han populations [n (%)]
Group n Genotype Allele
CC CT TT C T
Mulao 649 559 (86.10) 89 (13.70) 1 (0.20) 1207 (92.99) 91 (7.01)
Han 712 623 (87.50) 84 (11.80) 5 (0.70) 1330 (93.40) 94 (6.60)
x2 - 3.367 0.180
P - 0.186 0.671
Mulao
Male 290 246 (84.80) 44 (15.20) 0 (0) 536 (92.41) 44 (7.59)
Female 359 313 (87.20) 45 (12.50) 1 (0.30) 671 (93.45) 47 (6.55)
x2 - 1.725 0.533
P - 0.422 0.466
Han
Male 316 270 (85.40) 44 (14.00) 2 (0.60) 584 (92.41) 48 (7.59)
Female 396 353 (89.10) 40 (10.10) 3 (0.80) 746 (94.19) 46 (5.81)
x2 - 2.491 1.820
P - 0.288 0.177
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than the T allele non-carriers. The levels of TC, TG,
HDL-C, ApoB, and the ratio of ApoA1 to ApoB in Han
males were different between the CC and CT/TT geno-
types (P < 0.05-0.01), the T allele carriers had higher TC,
HDL-C levels and the ApoA1/ApoB ratio, and lower TG
and ApoB levels than the T allele non-carriers. The
levels of LDL-C, ApoB, and the ratio of ApoA1 to ApoB
in Han females were also different between the CC and
CT/TT genotypes (P < 0.05 for all), the T allele carriers
had higher LDL-C and ApoB levels and lower ApoA1/
ApoB ratio than the T allele non-carriers.
Risk factors for serum lipid parameters
Multiple linear regression analysis showed that serum TC
levels were correlated with genotypes in combined popula-
tion of Mulao and Han (P < 0.05), and in Han (P < 0.05)
but not in Mulao (Table 4).
When serum lipid data were analyzed according to gen-
der, the levels of HDL-C in Han were associated with geno-
types in males but not in females (P < 0.05, Table 4).
We also found that serum lipid parameters were cor-
related with several environmental factors such as age,
gender, BMI, alcohol consumption, cigarette smoking,
blood pressure and blood glucose in both ethnic groups
(P < 0.05-0.001, Tables 5 and 6).
Discussion
In the present study, we found that the levels of ApoB
were higher in Mulao than in Han (P < 0.001). There
were no significant differences in the levels of TC, TG,HDL-C, LDL-C, ApoA1 and the ratio of ApoA1 to ApoB
between the two ethnic groups. These findings are
somewhat inconsistent with our previous studies [9,10].
We previously showed that both LDL-C and ApoB levels
were higher in Mulao than in Han [9], or the levels of
ApoA1 were lower and the levels of ApoB were higher
in Mulao than in Han [10]. These discrepancies may be
owing to the different sampling from our previous strati-
fied randomized samples. It is universally recognized
that the concentration of lipids is influenced by environ-
mental factors [7] as well as genetic factors [9] and their
interactions [8]. The marriages of Mulao nationality are
traditionally arranged by elders when children were 12
or 13 years’ old. Unlike some conservative ethnic groups,
there is a preference for marriage to mother’s brother’s
daughter. Therefore, we believe that the intra-ethnic
marriage customs and unique traditions have made the
Mulao to be a genetic characteristics distinctively na-
tionality. The genetic background and some lipid-related
genes in Mulao may be different from those in Han
nationality.
The genotypic and allelic frequencies of MLXIPL/
TBL2 rs17145738 SNP in diverse racial/ethnic groups
are slightly different. The frequency of T allele was 12%
in European Americans, 9% in African Americans, 8% in
American Indians, 7% in Mexican Americans and His-
panics [13], and 13% in the Northern Swedish popula-
tion [22]. The frequency of T allele was 12% in Malay
population [23], which was similar to the InChianti sam-
ple of Italy [24]. Hegele et al. [25] reported that the fre-
quency of T allele was 5.1-11% in classical Fredrickson
hyperlipoproteinemic patients and 14.9% in normolipi-
demic controls. Wang et al. [25] showed that the fre-
quency of T allele was 6.8% in hypertriglyceridemic
patients and 13.1% in normal controls [26]. In the
present study, we showed that the frequency of T allele
was 7% in Mulao and 6.6% in Han, which was closer to
that in Mexican Americans and Hispanics [13] and the
hypertriglyceridemic patients [26], but was lower than
that in a multiethnic SHARE sample from Canada (the
minor allele frequency was 8% in South Asian, 11% in
Chinese, and 19% in European Caucasian; respectively)
[12]. There were no significant differences in the geno-
typic and allelic frequencies between males and females
in both ethnic groups. These findings were similar to the
results of a previous study [27], Polgár et al. [27] found
that the allelic frequency of MLXIPL/TBL2 rs17145738
SNP in patients with stroke did not significantly differ
from that in control group. These results indicate that
the genetic variation of MLXIPL/TBL2 may be similar in
the Mulao and Han populations.
The relationship between rs17145738 SNP and plasma
or serum lipid levels in previous GWAS is inconsistent
in multiethnic populations. Several GWAS showed that
Table 3 Comparison of the genotypes and serum lipid levels between the Mulao and Han populations
Ethnic group/Genotype n TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L) ApoA1 (g/L) ApoB (g/L) ApoA1/ApoB
Mulao
CC 559 5.06 ± 1.38 1.07 (0.76−1.57) 1.76 ± 0.48 2.92 ± 0.91 1.32 ± 0.41 0.95 ± 0.52 1.64 ± 1.09
CT/TT 90 5.14 ± 1.11 1.23 (0.84−1.72) 1.72 ± 0.42 2.97 ± 0.81 1.36 ± 0.33 1.07 ± 0.66 1.52 ± 0.59
F - 0.431 −1.993 0.982 0.876 1.249 4.015 1.391
P - 0.512 0.046 0.322 0.350 0.264 0.046 0.239
Han
CC 623 4.99 ± 0.98 1.07 (0.82−1.65) 1.73 ± 0.54 2.88 ± 0.83 1.34 ± 0.26 0.86 ± 0.20 1.64 ± 0.48
CT/TT 89 5.27 ± 1.14 0.98 (0.74−1.45) 1.78 ± 0.40 3.01 ± 0.76 1.36 ± 0.21 0.86 ± 0.16 1.63 ± 0.34
F - 8.065 −1.323 1.097 5.018 0.636 1.552 1.741
P - 0.005 0.186 0.295 0.025 0.425 0.213 0.187
Mulao/Male
CC 246 5.16 ± 1.60 1.15 (0.82−1.92) 1.74 ± 0.53 2.87 ± 0.92 1.32 ± 0.44 1.03 ± 0.62 1.52 ± 0.72
CT/TT 44 5.14 ± 1.22 1.25 (0.84−2.49) 1.71 ± 0.42 2.84 ± 0.64 1.36 ± 0.38 1.10 ± 0.72 1.48 ± 0.58
F - 0.193 −1.161 0.151 0.099 1.019 0.656 0.384
P - 0.661 0.245 0.698 0.754 0.314 0.419 0.536
Mulao/Female
CC 313 4.98 ± 1.18 1.00 (0.75−1.40) 1.78 ± 0.43 2.96 ± 0.91 1.32 ± 0.40 0.90 ± 0.41 1.73 ± 1.29
CT/TT 46 5.13 ± 1.00 1.12 (0.85−1.47) 1.73 ± 0.39 3.10 ± 0.93 1.36 ± 0.27 1.03 ± 0.59 1.57 ± 0.60
F - 1.168 −1.619 1.102 1.787 0.444 4.483 1.047
P - 0.280 0.105 0.294 0.182 0.506 0.035 0.307
Han/Male
CC 270 5.13 ± 0.98 1.22 (0.92−1.85) 1.65 ± 0.40 2.95 ± 0.82 1.34 ± 0.27 0.91 ± 0.20 1.53 ± 0.46
CT/TT 46 5.43 ± 1.42 0.90 (0.73−1.51) 1.79 ± 0.39 2.95 ± 0.74 1.40 ± 0.23 0.87 ± 0.17 1.66 ± 0.33
F - 5.895 −2.930 4.511 1.052 2.494 5.043 4.474
P - 0.016 0.003 0.034 0.306 0.115 0.025 0.035
Han/Female
CC 353 4.89 ± 0.97 0.97 (0.74−1.53) 1.79 ± 0.63 2.82 ± 0.83 1.34 ± 0.24 0.81 ± 0.19 1.73 ± 0.48
CT/TT 43 5.09 ± 0.73 1.20 (0.84−1.36) 1.78 ± 0.41 3.07 ± 0.78 1.32 ± 0.19 0.85 ± 0.15 1.60 ± 0.34
F - 2.878 0.941 0.320 4.892 1.252 4.653 6.316
P - 0.091 0.347 0.572 0.028 0.264 0.032 0.012
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoB,
apolipoprotein B; ApoA1/ApoB, the ratio of apolipoprotein A1 to apolipoprotein B. The association of genotypes and serum lipid parameters was tested by
analysis of covariance (co-variables include sex, age, BMI, blood pressure, alcohol consumption, and cigarette smoking). The value of TG was presented as median
(interquartile range), the difference between the genotypes was determined by the Wilcoxon-Mann–Whitney test.
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http://www.lipidworld.com/content/12/1/156the rs17145738 SNP contributed to elevated TG
[4,13,28,29] and HDL-C [4,13,28,29] concentrations.
Kathiresan et al. [13] found that the T allele was associ-
ated with higher HDL-C and lower TG concentrations
in European Ancestry. These findings are partly consist-
ent with our results. We found that the T allele carriers
in Han males had higher HDL-C and lower TG levels.
Moreover, Liu et al. [28] also reported that the
rs17145738 SNP was associated with TG (TG concentra-
tion increase of 0.17 mmol/L per C allele) and HDL-C
(HDL-C concentration increase of 0.04 mmol/L per T al-
lele) in a Chinese Han population from Shanghai. In
addition, Keebler et al. [29] showed that the T allele ofrs17145738 SNP was associated with HDL-C in Non-
Hispanic Whites but not in Non-Hispanic Black and
Mexican Americans, and was significantly associated
with TG in Non-Hispanic Whites and Mexican Ameri-
cans, but no in Non-Hispanic Black. A previous study
detecting the polygenic determinants of severe hypertri-
glyceridemia found that the rs17145738 SNP was signifi-
cantly associated with severe hypertriglyceridemia [26].
However, several previous studies failed to find a signifi-
cant association between the rs17145738 SNP and
plasma lipid levels [23,27]. Polgár et al. [27] did not con-
firm any associations between the rs17145738 SNP and
altered TG or other lipid parameters. Tai et al. [23] also
Table 4 Correlation between serum lipid parameters and genotypes in Mulao and Han populations
Lipid Relative factor Unstandardized coefficient Std. error Standardized coefficient t P
Mulao plus Han
TC Genotype 0.179 0.091 0.051 1.978 0.049
Han
TC Genotype 0.269 0.107 0.088 2.521 0.012
Han/male
HDL-C Genotype 0.122 0.061 0.108 2.006 0.046
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol. The correlation was determined by multivariable linear regression analysis with
stepwise modeling.
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http://www.lipidworld.com/content/12/1/156found that the rs17145738 SNP did not show any associ-
ation with lipid-related traits in Malay population. In the
present study, we found that the association of MLXIPL/
TBL2 rs17145738 SNP and serum lipid levels was differ-
ent between the Mulao and Han populations. The T al-
lele carriers in Mulao had higher TG and ApoB levels,
whereas the T allele carriers in Han had higher TC and
LDL-C levels than the T allele non-carriers. When serum
lipid parameters were analyzed according to gender, we
found that the T allele carriers had higher ApoB levels in
both Mulao and Han females than the T allele non-
carriers, but the T allele carriers had lower ApoB levels
in Han males than the T allele non-carriers. The T allele
carriers in Han had higher TC, HDL-C levels and
ApoA1/ApoB ratio and lower TG levels in males, and
higher LDL-C levels and lower ApoA1/ApoB ratio in fe-
males than the T allele non-carriers. Multiple linear re-
gression analysis showed that serum TC levels were
correlated with genotypes in combined population of
Mulao and Han, and in Han but not in Mulao. The
levels of HDL-C in Han were associated with genotypes
in males but not in females. These findings suggest that
the rs17145738 SNP can also influence other serum lipid
parameters except TG and HDL-C in our populations.
However, the reason for these different findings is un-
clear, probably because of different study designs, sample
size, sex and age structure, experimental technique and
multiethnic background trait, as well as different envir-
onmental and genetic factors and gene-environmental
interactions.
In the present study, we also found that the T allele car-
riers in Han females had higher ApoB levels and lower
ApoA1/ApoB ratio, whereas the T allele carriers in Han
males had lower ApoB levels and higher ApoA1/ApoB ratio
than the T allele non-carriers. These opposite effects of
rs17145738 SNP on serum lipid levels might exist in some
populations although it was not relevant in prior studies.
Thus, we hypothesize that there may be a sex-specific asso-
ciation of the MLXIPL/TBL2 rs17145738 SNP and serum
lipid levels in the Han population. In addition, the ratio of
ApoA1 to ApoB which reflect the cholesterol balance be-
tween antiatherogenic and atherogenic lipoprotein particleshas been demonstrated to have a great value in predicting
cardiovascular risk [3]. Low ratio of ApoA1 to ApoB re-
flects the potential risk of atherosclerosis. Furthermore, the
gonadal hormone is considered as a contribution factor on
lipid metabolism although the reasons for sex differences in
serum lipid levels are still unclear. It is generally believed
that androgens induce changes in serum lipid levels that
would predispose towards CAD, whereas estrogens are held
to opposite effects [30]. This conclusion makes us more
confusion. In theory, males have more CAD susceptibility
factors than females. But in the present study the T allele is
a protective factor in Han males (higher ApoA1/ApoB ra-
tio) whereas it is an unfavorable factor for CAD in Han fe-
males (lower ApoA1/ApoB ratio). This ambivalent
founding may be due to several potential limitations of this
study. First, the mean age (about 52 years) of the subjects
was older in the present study than in the other studies,
and the gonadal hormone levels may be low. Second, the
women accounted for about 55% of the subjects in the
current study. Epidemiological studies have provided abun-
dant evidence that serum lipid levels are closely related to
sex. Third, the sample size is a bit small. It may not be large
enough to detect the association of MLXIPL/TBL2
rs17145738 SNP and serum lipid levels in the subgroup
analyses. Finally, serum lipid levels are affected by multiple
environmental, genetic factors, and their interactions. Al-
though sex, age, BMI, blood pressure, alcohol consumption,
and cigarette smoking have been adjusted for the statistical
analysis, we cannot completely exclude the influence of
these factors on serum lipid levels between different alleles
or genotypes. To the best of our knowledge, however, the
association of MLXIPL/TBL2 rs17145738 SNP and serum
ApoB levels and the ApoA1/ApoB ratio has not been previ-
ously explored. Further studies are needed to clarify.
It is well known that serum lipid concentration is
highly heritable and is also modifiable by environmental
factors, as well as the gene-environmental interactions
[7,8]. In the present study, we also showed that serum
lipid parameters were correlated with age, gender, alco-
hol consumption, cigarette smoking, BMI, blood pres-
sure and blood glucose in both ethnic groups. These
results suggested that the environmental factors also play
Table 5 Correlation between serum lipid parameters and environmental risk factors in the Mulao and Han populations
Lipid parameter Risk factor Unstandardized coefficient Std. error Standardized coefficient t P
Mulao plus Han
TC Waist circumference 0.013 0.005 0.091 2.591 0.010
Age 0.011 0.002 0.138 5.122 0.000
Alcohol consumption 0.211 0.044 0.126 4.759 0.000
Body mass index 0.034 0.012 0.095 2.729 0.006
Diastolic blood pressure 0.007 0.003 0.071 2.564 0.010
TG Waist circumference 0.063 0.007 0.235 8.961 0.000
Alcohol consumption 0.523 0.081 0.169 6.498 0.000
Blood glucose 0.085 0.035 0.063 2.449 0.014
HDL-C Waist circumference −0.010 0.002 −0.161 −5.838 0.000
Alcohol consumption 0.117 0.023 0.166 5.214 0.000
Gender 0.127 0.032 0.126 2.958 0.000
Age 0.003 0.001 0.087 2.957 0.003
Systolic blood pressure −0.002 0.001 −0.064 −2.121 0.034
LDL-C Body mass index 0.049 0.007 0.187 7.152 0.000
Age 0.010 0.001 0.179 6.837 0.000
Cigarette smoking −0.096 0.042 −0.060 −2.279 0.023
ApoA1 Alcohol consumption 0.142 0.015 0.302 9.640 0.000
Gender 0.104 0.021 0.155 4.947 0.000
Age 0.001 0.001 0.058 2.215 0.027
ApoB Waist circumference 0.007 0.002 0.141 3.963 0.000
Nation −0.120 0.021 −0.148 −5.689 0.000
Gender −0.074 0.022 −0.091 −3.412 0.000
Blood glucose 0.022 0.006 0.089 3.373 0.004
Body mass index 0.010 0.004 0.082 2.360 0.011
ApoA1/ApoB Waist circumference −0.009 0.004 −0.094 −2.594 0.010
Blood glucose −0.038 0.013 −0.078 −2.906 0.004
Gender 0.212 0.050 0.134 4.204 0.000
Alcohol consumption 0.112 0.035 0.100 3.190 0.001
Body mass index −0.025 0.008 −0.105 −2.984 0.003
Mulao
TC Body mass index 0.075 0.017 0.169 4.395 0.000
Age 0.011 0.003 0.123 3.204 0.001
Alcohol consumption 0.194 0.070 0.107 2.791 0.005
TG Waist circumference 0.061 0.011 0.212 5.596 0.000
Alcohol consumption 0.598 0.124 0.183 4.830 0.000
HDL-C Body mass index −0.036 0.006 −0.230 −6.053 0.000
Alcohol consumption 0.111 0.029 0.175 3.793 0.000
Gender 0.120 0.044 0.127 2.755 0.006
LDL-C Body mass index 0.053 0.011 0.177 4.625 0.000
Age 0.008 0.002 0.137 3.577 0.000
Alcohol consumption −0.132 0.046 −0.109 −2.846 0.005
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Table 5 Correlation between serum lipid parameters and environmental risk factors in the Mulao and Han populations
(Continued)
ApoA1 Alcohol consumption 0.146 0.025 0.268 5.766 0.000
Gender 0.122 0.038 0.150 3.226 0.001
Pulse pressure 0.002 0.001 0.086 2.252 0.025
ApoB Waist circumference 0.013 0.002 0.198 5.143 0.000
ApoA1/ApoB Waist circumference −0.018 0.005 −0.144 −3.692 0.000
Blood glucose −0.051 0.025 −0.080 −2.051 0.041
Han
TC Diastolic blood pressure 0.016 0.003 0.178 4.783 0.000
Alcohol consumption 0.253 0.054 0.168 4.699 0.000
Age 0.010 0.002 0.153 4.159 0.000
Body mass index 0.043 0.010 0.150 4.143 0.000
TG Waist circumference 0.058 0.009 0.231 6.404 0.000
Cigarette smoking 0.638 0.124 0.178 5.140 0.000
Blood glucose 0.218 0.043 0.184 5.086 0.000
Diastolic blood pressure 0.029 0.006 0.167 4.559 0.000
Age −0.017 0.005 −0.130 −3.514 0.000
HDL-C Waist circumference −0.009 0.003 −0.137 −3.629 0.000
Gender 0.158 0.046 0.148 3.416 0.001
Alcohol consumption 0.105 0.034 0.134 3.099 0.002
LDL-C Age 0.012 0.002 0.216 6.053 0.000
Body mass index 0.047 0.008 0.203 5.620 0.000
Cigarette smoking −0.267 0.068 −0.176 −3.916 0.000
Gender −0.230 0.075 −0.140 −3.086 0.002
ApoA1 Alcohol consumption 0.128 0.016 0.340 7.839 0.000
Gender 0.107 0.024 0.211 4.478 0.000
Body mass index −0.007 0.003 −0.097 −2.695 0.007
Cigarette smoking 0.056 0.022 0.119 2.558 0.011
ApoB Waist circumference 0.004 0.001 0.179 4.262 0.000
Alcohol consumption 0.054 0.010 0.187 5.631 0.000
Blood glucose 0.020 0.004 0.167 5.018 0.000
Body mass index 0.011 0.002 0.195 4.746 0.000
Diastolic blood pressure −0.002 0.001 −0.099 −2.314 0.021
ApoA1/ApoB Body mass index −0.024 0.006 −0.186 −4.256 0.000
Diastolic blood pressure −0.003 0.001 −0.132 −3.733 0.000
Waist circumference −0.008 0.003 −0.134 −3.045 0.002
Gender 0.239 0.043 0.256 5.521 0.000
Cigarette smoking 0.151 0.039 0.176 3.886 0.000
Alcohol consumption 0.071 0.029 0.103 2.436 0.015
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoB,
apolipoprotein B; ApoA1/Apo B, the ratio of apolipoprotein A1 to apolipoprotein B. The correlation was determined by multivariable linear regression analysis with
stepwise modeling.
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http://www.lipidworld.com/content/12/1/156an important role in determining serum lipid levels in
our populations. Although Mulao and Han reside in the
same region, there was significant difference in their diet
and lifestyle. Rice and corn are the staple foods in bothethnic groups. Mulao people favour the sour food, they
like to eat cold foods along with acidic and spicy dishes,
so bean soy sauce and pickled vegetables are among
their most popular dishes. They also prefer to eat animal
Table 6 Correlative factors for serum lipid parameters between males and females in both ethnic groups
Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient t P
Mulao / Male
TC Body mass index 0.103 0.030 0.197 3.418 0.001
Alcohol consumption 0.201 0.100 0.116 2.018 0.045
TG Waist circumference 0.097 0.022 0.250 4.419 0.000
Alcohol consumption 0.516 0.215 0.136 2.400 0.017
HDL-C Waist circumference −0.013 0.003 −0.227 −4.022 0.000
Alcohol consumption 0.112 0.033 0.194 3.428 0.001
LDL-C Body mass index 0.046 0.017 0.154 2.651 0.008
Alcohol consumption −0.126 0.057 −0.128 −0.128 0.028
ApoA1 Alcohol consumption 0.141 0.027 0.293 5.279 0.000
Pulse pressure 0.004 0.002 0.144 2.589 0.010
Blood glucose −0.029 0.012 −0.129 −2.320 0.021
ApoB Waist circumference 0.012 0.004 0.172 2.957 0.003
ApoA1/ApoB Waist circumference −0.019 0.005 −0.235 −4.158 0.000
Alcohol consumption 0.141 0.044 0.179 3.197 0.002
Blood glucose −0.042 0.021 −0.115 −2.034 0.043
Mulao / Female
TC Age 0.015 0.004 0.196 3.803 0.000
Body mass index 0.053 0.019 0.139 2.695 0.007
TG Alcohol consumption 1.434 0.306 0.237 4.683 0.000
Waist circumference 0.024 0.006 0.189 3.728 0.000
HDL-C Body mass index −0.032 0.007 −0.230 −4.459 0.000
LDL-C Age 0.013 0.003 0.228 4.500 0.000
Body mass index 0.056 0.015 0.187 3.682 0.000
ApoB Cigarette smoking 1.217 0.302 0.205 4.035 0.000
Waist circumference 0.010 0.003 0.182 3.581 0.000
Age 0.003 0.001 0.118 2.321 0.021
ApoA1/ApoB Age −0.010 0.004 −0.133 −2.526 0.012
Han / Male
TC Diastolic blood pressure 0.028 0.005 0.305 5.788 0.000
Alcohol consumption 0.242 0.067 0.191 3.637 0.000
TG Waist circumference 0.065 0.018 0.200 3.653 0.000
Cigarette smoking 0.903 0.223 0.216 4.047 0.000
Blood glucose 0.341 0.080 0.237 4.239 0.000
Diastolic blood pressure 0.045 0.012 0.203 3.708 0.000
Age −0.019 0.009 −0.121 −2.185 0.030
HDL-C Waist circumference −0.012 0.003 −0.231 −4.236 0.000
Alcohol consumption 0.096 0.026 0.201 3.673 0.000
LDL-C Cigarette smoking −0.281 0.072 −0.212 −3.926 0.000
Body mass index 0.041 0.011 0.205 3.803 0.000
ApoA1 Alcohol consumption 0.127 0.017 0.395 7.437 0.000
Body mass index −0.008 0.003 −0.120 −2.338 0.020
Cigarette smoking 0.051 0.023 0.114 2.161 0.031
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Table 6 Correlative factors for serum lipid parameters between males and females in both ethnic groups (Continued)
ApoB Waist circumference 0.004 0.001 0.154 2.716 0.007
Diastolic blood pressure 0.004 0.001 0.226 4.559 0.000
Alcohol consumption 0.048 0.011 0.208 4.289 0.000
Body mass index 0.010 0.003 0.208 3.744 0.000
Blood glucose 0.018 0.005 0.167 3.443 0.001
ApoA1/ApoB Body mass index −0.027 0.006 −0.251 −4.215 0.000
Cigarette smoking 0.110 0.039 0.152 2.838 0.005
Waist circumference −0.010 0.003 −0.174 −2.909 0.004
Alcohol consumption 0.071 0.029 0.134 2.474 0.014
Han/Female
TC Age 0.021 0.003 0.329 7.023 0.000
Body mass index 0.065 0.015 0.205 4.378 0.000
TG Waist circumference 0.050 0.008 0.301 6.277 0.000
Diastolic blood pressure 0.017 0.006 0.156 3.072 0.002
Blood glucose 0.103 0.039 0.130 2.666 0.008
Age −0.009 0.004 −0.109 −2.115 0.035
HDL-C Systolic blood pressure −0.006 0.002 −0.188 −3.282 0.001
Age 0.007 0.002 0.171 2.983 0.003
LDL-C Age 0.019 0.003 0.337 6.977 0.000
Waist circumference 0.020 0.005 0.176 3.756 0.000
Cigarette smoking −0.601 0.216 −0.135 −2.785 0.006
ApoA1 Alcohol consumption 0.185 0.064 0.145 2.903 0.004
ApoB Waist circumference 0.003 0.002 0.116 1.725 0.085
Pulse pressure 0.001 0.001 0.110 2.187 0.029
Blood glucose 0.017 0.006 0.145 3.065 0.002
Body mass index 0.015 0.004 0.254 3.759 0.000
Cigarette smoking −0.167 0.046 −0.169 −3.600 0.000
Age 0.002 0.001 0.167 3.166 0.002
ApoA1/ApoB Systolic blood pressure −0.006 0.001 −0.230 −4.807 0.000
Cigarette smoking 0.616 0.117 0.243 5.261 0.000
Body mass index −0.035 0.007 −0.225 −4.853 0.000
Blood glucose −0.029 0.015 −0.093 −1.973 0.049
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoB,
apolipoprotein B; ApoA1/ApoB, the ratio of apolipoprotein A1 to apolipoprotein B. The correlative factors were determined by multivariable linear regression
analysis with stepwise modeling.
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http://www.lipidworld.com/content/12/1/156offal which contains abundant saturated fatty acid. It has
been widely accepted that high-fat diets, particularly
those that contain large quantities of saturated fatty
acids, increase serum cholesterol levels [6]. The American
Heart Association’s recently advocate a population-wide
limitation of dietary saturated fat to < 10% of calories
and cholesterol < 300 mg/day to build a desirable blood
cholesterol and lipoprotein profile [31]. We also found
that the percentages of subjects who consumed alcohol
were higher in Mulao than in Han. That may because
Mulao, regardless of men and women, all favour glutin-
ous rice wine more than Han. In September, the riceharvest, the Mulao people like to use the best rice
brewed into a mellow and after-effect of great glutinous
rice wine. So the Mulao nationality called The Double
Ninth Festival “the wine”. The past few decades, re-
searchers focused on the relationship between alcohol
and blood lipid concentrations, because of the interest
in the U shaped or J shaped between alcohol and athero-
genesis [32]. Numerous studies showed that moderate
alcohol intake has been associated with reduced cardio-
vascular events [33,34]. These results probably attributed
to the changes in serum HDL-C, TG and ApoA1 levels
[34,35]. However, alcohol consumption was also
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http://www.lipidworld.com/content/12/1/156associated with worse hematological values of TC and
LDL-C levels. Results from the Italian Longitudinal Study
on Aging showed that in elderly men (65–84 years) alco-
hol consumption increases serum LDL-C levels [36]. A
previous study of Turks also found that the levels of
LDL-C, as well as ApoB and TG were increased in male
drinkers, while females had decreased TG and no change
in LDL-C or ApoB with alcohol [37].
Conclusions
The present study shows that the genotypic and allelic fre-
quencies of MLXIPL/TBL2 rs17145738 SNP were not dif-
ferent between the Mulao and Han populations or between
males and females in both ethnic groups. But the associ-
ation of the rs17145738 SNP and serum lipid levels is dif-
ferent between the two ethnic groups. There is a sex-
specific association of MLXIPL/TBL2 rs17145738 SNP and
serum lipid levels in the both ethnic groups.
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